United States Conjunctivitis Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Conjunctivitis Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by End User
1.3 United States Conjunctivitis Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Conjunctivitis Overall Market Size
2.1 United States Conjunctivitis Market Size: 2021 VS 2027
2.2 United States Conjunctivitis Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Conjunctivitis Sales: 2016-2027
3 Company Landscape
3.1 Top Conjunctivitis Players in United States Market
3.2 Top United States Conjunctivitis Companies Ranked by Revenue
3.3 United States Conjunctivitis Revenue by Companies
3.4 United States Conjunctivitis Sales by Companies
3.5 United States Conjunctivitis Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Conjunctivitis Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Conjunctivitis Product Type
3.8 Tier 1, Tier 2 and Tier 3 Conjunctivitis Players in United States Market
3.8.1 List of Tier 1 Conjunctivitis Companies in United States
3.8.2 List of Tier 2 and Tier 3 Conjunctivitis Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Conjunctivitis Market Size Markets, 2021 & 2027
4.1.2 Antibiotic
4.1.3 Pills
4.1.4 Ointment
4.2 By Type - United States Conjunctivitis Revenue & Forecasts
4.2.1 By Type - United States Conjunctivitis Revenue, 2016-2021
4.2.2 By Type - United States Conjunctivitis Revenue, 2022-2027
4.2.3 By Type - United States Conjunctivitis Revenue Market Share, 2016-2027
4.3 By Type - United States Conjunctivitis Sales & Forecasts
4.3.1 By Type - United States Conjunctivitis Sales, 2016-2021
4.3.2 By Type - United States Conjunctivitis Sales, 2022-2027
4.3.3 By Type - United States Conjunctivitis Sales Market Share, 2016-2027
4.4 By Type - United States Conjunctivitis Price (Manufacturers Selling Prices), 2016-2027
5 Sights by End User
5.1 Overview
5.1.1 By End User - United States Conjunctivitis Market Size, 2021 & 2027
5.1.2 Newborns
5.1.3 Children
5.1.4 Adults
5.2 By End User - United States Conjunctivitis Revenue & Forecasts
5.2.1 By End User - United States Conjunctivitis Revenue, 2016-2021
5.2.2 By End User - United States Conjunctivitis Revenue, 2022-2027
5.2.3 By End User - United States Conjunctivitis Revenue Market Share, 2016-2027
5.3 By End User - United States Conjunctivitis Sales & Forecasts
5.3.1 By End User - United States Conjunctivitis Sales, 2016-2021
5.3.2 By End User - United States Conjunctivitis Sales, 2022-2027
5.3.3 By End User - United States Conjunctivitis Sales Market Share, 2016-2027
5.4 By End User - United States Conjunctivitis Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Novartis (CH)
6.1.1 Novartis (CH) Corporation Information
6.1.2 Novartis (CH) Overview
6.1.3 Novartis (CH) Conjunctivitis Sales and Revenue in United States Market (2016-2021)
6.1.4 Novartis (CH) Conjunctivitis Product Description
6.1.5 Novartis (CH) Recent Developments
6.2 Santen Pharmaceutical (JP)
6.2.1 Santen Pharmaceutical (JP) Corporation Information
6.2.2 Santen Pharmaceutical (JP) Overview
6.2.3 Santen Pharmaceutical (JP) Conjunctivitis Sales and Revenue in United States Market (2016-2021)
6.2.4 Santen Pharmaceutical (JP) Conjunctivitis Product Description
6.2.5 Santen Pharmaceutical (JP) Recent Developments
6.3 Bausch & Lomb (US)
6.3.1 Bausch & Lomb (US) Corporation Information
6.3.2 Bausch & Lomb (US) Overview
6.3.3 Bausch & Lomb (US) Conjunctivitis Sales and Revenue in United States Market (2016-2021)
6.3.4 Bausch & Lomb (US) Conjunctivitis Product Description
6.3.5 Bausch & Lomb (US) Recent Developments
6.4 Allergan (US)
6.4.1 Allergan (US) Corporation Information
6.4.2 Allergan (US) Overview
6.4.3 Allergan (US) Conjunctivitis Sales and Revenue in United States Market (2016-2021)
6.4.4 Allergan (US) Conjunctivitis Product Description
6.4.5 Allergan (US) Recent Developments
6.5 Sun Pharmaceutical (ID)
6.5.1 Sun Pharmaceutical (ID) Corporation Information
6.5.2 Sun Pharmaceutical (ID) Overview
6.5.3 Sun Pharmaceutical (ID) Conjunctivitis Sales and Revenue in United States Market (2016-2021)
6.5.4 Sun Pharmaceutical (ID) Conjunctivitis Product Description
6.5.5 Sun Pharmaceutical (ID) Recent Developments
6.6 Akorn (US)
6.6.1 Akorn (US) Corporation Information
6.6.2 Akorn (US) Overview
6.6.3 Akorn (US) Conjunctivitis Sales and Revenue in United States Market (2016-2021)
6.6.4 Akorn (US) Conjunctivitis Product Description
6.6.5 Akorn (US) Recent Developments
6.7 Freda (CN)
6.7.1 Freda (CN) Corporation Information
6.7.2 Freda (CN) Overview
6.7.3 Freda (CN) Conjunctivitis Sales and Revenue in United States Market (2016-2021)
6.7.4 Freda (CN) Conjunctivitis Product Description
6.7.5 Freda (CN) Recent Developments
6.8 Sinqi (CN)
6.8.1 Sinqi (CN) Corporation Information
6.8.2 Sinqi (CN) Overview
6.8.3 Sinqi (CN) Conjunctivitis Sales and Revenue in United States Market (2016-2021)
6.8.4 Sinqi (CN) Conjunctivitis Product Description
6.8.5 Sinqi (CN) Recent Developments
6.9 Univision (CN)
6.9.1 Univision (CN) Corporation Information
6.9.2 Univision (CN) Overview
6.9.3 Univision (CN) Conjunctivitis Sales and Revenue in United States Market (2016-2021)
6.9.4 Univision (CN) Conjunctivitis Product Description
6.9.5 Univision (CN) Recent Developments
7 United States Conjunctivitis Production Capacity, Analysis
7.1 United States Conjunctivitis Production Capacity, 2016-2027
7.2 Conjunctivitis Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Conjunctivitis Supply Chain Analysis
9.1 Conjunctivitis Industry Value Chain
9.2 Conjunctivitis Upstream Market
9.3 Conjunctivitis Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Conjunctivitis Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Conjunctivitis in United States Market
Table 2. Top Conjunctivitis Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Conjunctivitis Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Conjunctivitis Revenue Share by Companies, 2016-2021
Table 5. United States Conjunctivitis Sales by Companies, (K Units), 2016-2021
Table 6. United States Conjunctivitis Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Conjunctivitis Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Conjunctivitis Product Type
Table 9. List of Tier 1 Conjunctivitis Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Conjunctivitis Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Antibiotic
Table 12. Major Manufacturers of Pills
Table 13. By Type - United States Conjunctivitis Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Conjunctivitis Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Conjunctivitis Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Conjunctivitis Sales (K Units), 2016-2021
Table 17. By Type - United States Conjunctivitis Sales (K Units), 2022-2027
Table 18. By End User - United States Conjunctivitis Revenue, (US$, Mn), 2021 VS 2027
Table 19. By End User - United States Conjunctivitis Revenue (US$, Mn), 2016-2021
Table 20. By End User - United States Conjunctivitis Revenue (US$, Mn), 2022-2027
Table 21. By End User - United States Conjunctivitis Sales (K Units), 2016-2021
Table 22. By End User - United States Conjunctivitis Sales (K Units), 2022-2027
Table 23. Novartis (CH) Corporation Information
Table 24. Novartis (CH) Description and Major Businesses
Table 25. Novartis (CH) Conjunctivitis Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. Novartis (CH) Conjunctivitis Product
Table 27. Novartis (CH) Recent Developments
Table 28. Santen Pharmaceutical (JP) Corporation Information
Table 29. Santen Pharmaceutical (JP) Description and Major Businesses
Table 30. Santen Pharmaceutical (JP) Conjunctivitis Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. Santen Pharmaceutical (JP) Conjunctivitis Product
Table 32. Santen Pharmaceutical (JP) Recent Developments
Table 33. Bausch & Lomb (US) Corporation Information
Table 34. Bausch & Lomb (US) Description and Major Businesses
Table 35. Bausch & Lomb (US) Conjunctivitis Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. Bausch & Lomb (US) Conjunctivitis Product
Table 37. Bausch & Lomb (US) Recent Developments
Table 38. Allergan (US) Corporation Information
Table 39. Allergan (US) Description and Major Businesses
Table 40. Allergan (US) Conjunctivitis Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. Allergan (US) Conjunctivitis Product
Table 42. Allergan (US) Recent Developments
Table 43. Sun Pharmaceutical (ID) Corporation Information
Table 44. Sun Pharmaceutical (ID) Description and Major Businesses
Table 45. Sun Pharmaceutical (ID) Conjunctivitis Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. Sun Pharmaceutical (ID) Conjunctivitis Product
Table 47. Sun Pharmaceutical (ID) Recent Developments
Table 48. Akorn (US) Corporation Information
Table 49. Akorn (US) Description and Major Businesses
Table 50. Akorn (US) Conjunctivitis Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. Akorn (US) Conjunctivitis Product
Table 52. Akorn (US) Recent Developments
Table 53. Freda (CN) Corporation Information
Table 54. Freda (CN) Description and Major Businesses
Table 55. Freda (CN) Conjunctivitis Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 56. Freda (CN) Conjunctivitis Product
Table 57. Freda (CN) Recent Developments
Table 58. Sinqi (CN) Corporation Information
Table 59. Sinqi (CN) Description and Major Businesses
Table 60. Sinqi (CN) Conjunctivitis Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 61. Sinqi (CN) Conjunctivitis Product
Table 62. Sinqi (CN) Recent Developments
Table 63. Univision (CN) Corporation Information
Table 64. Univision (CN) Description and Major Businesses
Table 65. Univision (CN) Conjunctivitis Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 66. Univision (CN) Conjunctivitis Product
Table 67. Univision (CN) Recent Developments
Table 68. Conjunctivitis Production Capacity (K Units) of Key Manufacturers in United States Market, 2019-2021 (K Units)
Table 69. United States Conjunctivitis Capacity Market Share of Key Manufacturers, 2019-2021
Table 70. Conjunctivitis Market Opportunities & Trends in United States Market
Table 71. Conjunctivitis Market Drivers in United States Market
Table 72. Conjunctivitis Market Restraints in United States Market
Table 73. Conjunctivitis Raw Materials
Table 74. Conjunctivitis Raw Materials Suppliers in United States Market
Table 75. Typical Conjunctivitis Downstream
Table 76. Conjunctivitis Downstream Clients in United States Market
Table 77. Conjunctivitis Distributors and Sales Agents in United States Market
List of FiguresFigure 1. Conjunctivitis Product Picture
Figure 2. Conjunctivitis Segment by Type
Figure 3. Conjunctivitis Segment by End User
Figure 4. United States Conjunctivitis Market Overview: 2020
Figure 5. United States Conjunctivitis Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Conjunctivitis Revenue, 2016-2027 (US$, Mn)
Figure 7. Conjunctivitis Sales in United States Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Conjunctivitis Revenue in 2020
Figure 9. Antibiotic Product Picture
Figure 10. Pills Product Picture
Figure 11. Ointment Product Picture
Figure 12. By Type - United States Conjunctivitis Sales Market Share, 2016-2027
Figure 13. By Type - United States Conjunctivitis Revenue Market Share, 2016-2027
Figure 14. By Type - United States Conjunctivitis Price (USD/Unit), 2016-2027
Figure 15. Newborns
Figure 16. Children
Figure 17. Adults
Figure 18. By End User - United States Conjunctivitis Sales Market Share, 2016-2027
Figure 19. By End User - United States Conjunctivitis Revenue Market Share, 2016-2027
Figure 20. By End User - United States Conjunctivitis Price (USD/Unit), 2016-2027
Figure 21. Novartis (CH) Conjunctivitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Santen Pharmaceutical (JP) Conjunctivitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Bausch & Lomb (US) Conjunctivitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Allergan (US) Conjunctivitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Sun Pharmaceutical (ID) Conjunctivitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Akorn (US) Conjunctivitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Freda (CN) Conjunctivitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Sinqi (CN) Conjunctivitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Univision (CN) Conjunctivitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. United States Conjunctivitis Production Capacity (K Units), 2016-2027
Figure 31. Conjunctivitis Industry Value Chain
Figure 32. Marketing Channels